Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors-Reference-Cited by-同舟云学术

Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors

Published:2018-04-27 Issue:6 Volume:2 Page:718-731
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Jiao Jingjing¹,Watt Gordon P.¹²,Stevenson Heather L.³,Calderone Tiffany L.¹,Fisher‐Hoch Susan P.²,Ye Yuanqing⁴,Wu Xifeng⁴,Vierling John M.⁵,Beretta Laura¹^ORCID

Affiliation:

1. Department of Molecular and Cellular OncologyUniversity of Texas MD Anderson Cancer CenterHouston TX

2. School of Public HealthUniversity of Texas Health Science Center at HoustonBrownsville Regional Campus Brownsville TX

3. Department of PathologyUniversity of Texas Medical BranchGalveston TX

4. Department of EpidemiologyUniversity of Texas MD Anderson Cancer CenterHouston TX

5. Departments of Medicine and SurgeryBaylor College of MedicineHouston TX

Funder

National Institutes of Health

University of Texas MD Anderson Cancer Center

National Cancer Institute

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1187

Reference43 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer

3. Prognostic prediction and treatment strategy in hepatocellular carcinoma

4. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

5. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening, Surveillance, and Prevention of Hepatocellular Carcinoma;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

2. Developments and current status of cell‐free DNA in the early detection and management of hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2023-11-21

3. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives;Clinical Chemistry;2023-11-14

4. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?;International Journal of Molecular Sciences;2023-09-18

5. Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications;Biomedicines;2023-08-21